ZPD A/S: Financial statements 2022
CVR: 32834825
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
ZPD A/S (CVR 32834825) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 37,256,000 and a net result of DKK 7,067,000 compared with DKK 6,963,000 the year before. That is an increase of 5.8% compared with the year before. Equity in the 2022 report amounted to DKK 185,232,000. The solvency ratio was 94%. The company had 35 employees in the financial year.
- Gross Profit
- DKK 37,256,000
- Profit/Loss
- DKK 7,067,000
- Equity
- DKK 185,232,000
- Total Assets
- DKK 197,014,000
- Employees
- 35
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 37.3 mio. | 7.1 mio. | 185.2 mio. | 35 |
| 2021 | - | 35.2 mio. | 7 mio. | 178.2 mio. | 36 |
| 2020 | - | 35.6 mio. | 6 mio. | 171.2 mio. | 34 |
| 2019 | - | 36.8 mio. | 7.7 mio. | 165.2 mio. | 33 |
| 2018 | - | 41.5 mio. | 11.4 mio. | 157.5 mio. | 32 |
Official annual report
Keep an eye on ZPD A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ZPD A/S has published its annual report for 2021. Gross profit came to DKK 35,200,000, and the net result was DKK 6,963,000.
As of January 1, 2022, Hiroyuki Shinya is registered as director of ZPD A/S.
About ZPD A/S
ZPD A/S is a Danish company of the type Aktieselskab based in Esbjerg, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named BIOFAC ESBJERG A/S. The management consists of Frank Marek and Hiroyuki Shinya. The board consists of Masakazu Sakurai (chair), Frank Marek and Ken Motegi. The company is owned by Zeria Pharmaceutical Co. Ltd.. The company has 54 employees (2026). In 2025, the company reported a gross profit of DKK 52,704,000 and a net result of DKK 10,220,000 compared with DKK 12,864,000 the year before. Equity in the 2025 report amounted to DKK 217,641,000.